Mass or routine antenatal toxoplasmosis screening is cost effective and not appropriate to practice particularly in limited resource settings or low incidence of congenital toxoplasmosis, however, it could be justified in the area where high prevalence of Toxoplasma infection affects mothers, congenital toxoplasmosis and in countries where TORCHs screening is an applicable tool in that setting.